Is Detection of Asymptomatic Recurrence after Curative Resection Associated with Improved Survival in Patients with Gastric Cancer?

详细信息	查看全文 | 推荐本文 |

• 作者：Joseph J. Bennett ; Mithat Gonen ; Michael D’ ; Angelica ; David P. Jaques ; Murray F. Brennan and Daniel G. Coit
• 刊名：Journal of the American College of Surgeons
• 出版年：2005
• 期刊代码：175_10727515
• 类别：med
• 出版时间：2005
• 卷：201
• 期：4
• 页码：503-510
• 文件大小：256 K

摘要

Background

It is not clear if more intense surveillance is associated with improved survival after curative resection for cancer. In the context of a followup program after curative gastrectomy, recurrence and survival were investigated for patients presenting with either symptomatic or asymptomatic recurrence.

Study design

A prospectively maintained gastric cancer database was used to identify all patients who underwent a curative (R0) gastrectomy from July 1985 to June 2000. Survival curves were generated for patients with either symptomatic or asymptomatic recurrence, and the prognostic variables associated with outcomes were identified.

Results

Of 1,172 patients who underwent a curative (R0) gastrectomy, 561 patients (48%) had documented recurrence and 382 patients had complete data about symptoms. Median time to recurrence was 10.8months for asymptomatic patients and 12.4months for symptomatic patients (p = NS). Median postrecurrence survival was 13.5months for asymptomatic patients and 4.8months for symptomatic patients (p < 0.01). Median disease-specific survival was 29.4months for asymptomatic patients and 21.6months for symptomatic patients (p < 0.05). Variables predictive of poor postrecurrence survival included symptomatic recurrence, advanced stage (III/IV), poor differentiation, short disease-free interval (<12months), and multiple sites of recurrence.

Conclusions

Followup did not identify asymptomatic recurrence earlier than symptomatic recurrence. Patients with symptomatic recurrence have more aggressive disease with a shorter postrecurrence survival. The impact of detecting asymptomatic recurrence in the course of followup after curative gastrectomy could not be distinguished from the effects of four powerful biologic variables that also interact to govern outcomes.